A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Conditions: Sarcoma,Soft Tissue Interventions: Drug: INT230-6; Drug: Eribulin; Drug: Trabectedin; Drug: Pazopanib Sponsors: Intensity Therapeutics, Inc.; Premier Research Group plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials